🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

138 results for “qing” Clear

  1. PB101 plus EGFR-TKI including gefitinib, erlotinib, afatinib, or osimertinib

    Chongqing Precision Biotech Co., Ltd

    Non-small Cell Lung Cancer

    phase 1 mab completed

    1 trial

  2. PBCAR19B

    Chongqing Precision Biotech Co., Ltd

    CD19 Expressing Malignancies

    phase 1 gene therapy completed

    1 trial

  3. PBCAR269A

    Chongqing Precision Biotech Co., Ltd

    Relapsed/Refractory Multiple Myeloma

    phase 1 gene therapy terminated

    1 trial

  4. PBGENE-HBV

    Chongqing Precision Biotech Co., Ltd

    HEPATITIS B CHRONIC

    phase 1 mab active

    1 trial

  5. PIC1 Injection

    Chongqing Precision Biotech Co., Ltd

    Non-Hodgkin Lymphoma

    phase 1 mab active

    1 trial

  6. PRAX-628

    Chongqing Precision Biotech Co., Ltd

    Healthy

    phase 1 small molecule active

    1 trial

  7. PTOC1

    Chongqing Precision Biotech Co., Ltd

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  8. Qing'E pill

    Shanghai University of Traditional Chinese Medicine

    Menopause

    phase 1 small molecule completed

    1 trial

  9. RUC-4 Compound

    Chongqing Precision Biotech Co., Ltd

    Coronary Disease

    phase 1 small molecule completed

    1 trial

  10. TAEST16001

    Chongqing Precision Biotech Co., Ltd

    Liver Cancer Stage IV

    phase 1 small molecule completed

    1 trial

  11. TAEST16001 cells

    Chongqing Precision Biotech Co., Ltd

    Soft Tissue Sarcoma

    phase 1 mab active

    1 trial

  12. TQF3250 placebo

    Chia Tai Tianqing Pharmaceutical Group Co.,

    Hyperglycemia

    phase 1 small molecule active

    1 trial

  13. Targeted CEA CAR-T

    Chongqing Precision Biotech Co., Ltd

    Advanced Lung Cancer

    phase 1 mab active

    4 trials

  14. Yinhu Qingwen Granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Viral Pneumonia

    phase 1 small molecule active

    1 trial

  15. [11C]CPPC Injection

    Chongqing Precision Biotech Co., Ltd

    Amyotrophic Lateral Sclerosis

    phase 1 small molecule terminated

    1 trial

  16. anti-BCMA/CD70-CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    CAR T Cell Therapy

    phase 1 mab active

    1 trial

  17. anti-CD19 CAR NK

    Chongqing Precision Biotech Co., Ltd

    NHL

    phase 1 mab active

    1 trial

  18. anti-CD19-CAR-T cells

    Chongqing Precision Biotech Co., Ltd

    Systemic Lupus Erythematosus

    phase 1 mab active

    1 trial

  19. pCAR-19B cells

    Chongqing Precision Biotech Co., Ltd

    Acute Lymphoblastic Leukemia, in Relapse

    phase 1 mab active

    1 trial

  20. ​​A Phase 1, Open-Label, Multiple-Part Trial to Evaluate the Drug-Drug Interaction Potential of PRAX-628 in Healthy Participants​

    Chongqing Precision Biotech Co., Ltd

    Epilepsy

    phase 1 other active

    1 trial

  21. BLB-750 Vaccine (Qinghai RG strain)

    Takeda

    Pandemic Influenza Prevention

    approved mab completed

    1 trial

  22. Dexamethasone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Localized Primary Osteoarthritis of Both Hips (Diagnosis)

    approved small molecule active

    1 trial

  23. Hepatitis B vaccine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Hepatitis B Vaccination, HIV

    approved mab active

    1 trial

  24. Provase

    Chongqing Precision Biotech Co., Ltd

    Pruritus

    approved other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources